Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Valvular Heart Disease

  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 42 articles:
HTML format

Single Articles

    September 2022
  1. MYLONAS KS, Tasoudis PT, Pavlopoulos D, Kanakis M, et al
    Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data.
    Am Heart J. 2022 Sep 14. pii: S0002-8703(22)00186.
    PubMed     Abstract available

    August 2022
  2. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    PubMed     Abstract available

  3. PAVLIDES GS, Chatzizisis YS, Porter TR
    Integrating Hemodynamics with Ventricular and Valvular Remodeling in Aortic Stenosis. A Paradigm Shift in Therapeutic Decision Making.
    Am Heart J. 2022 Aug 12. pii: S0002-8703(22)00165.
    PubMed     Abstract available

    June 2022
  4. TOMII D, Pilgrim T, Heg D, Reineke D, et al
    Reply: Correlation of aortic root dimensions in patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2022;248:166-168.

  5. GUPTA K, Lee JC
    Assessment of sinus of valsalva dimensions before TAVI: An independent predictor of worse outcomes?
    Am Heart J. 2022;248:165.

    February 2022
  6. LINDER M, Higgen FL, Voigtlander L, Weimann J, et al
    Stroke events after transcatheter aortic valve implantation: Temporal relationships and affected brain regions.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00030.
    PubMed     Abstract available

    January 2022
  7. HERRMANN HC, Abdel-Wahab M, Attizzani GF, Batchelor W, et al
    Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial).
    Am Heart J. 2022;243:92-102.
    PubMed     Abstract available

  8. BUTALA NM, Song Y, Shen C, Cohen DJ, et al
    Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial.
    Am Heart J. 2022;243:77-86.
    PubMed     Abstract available

    December 2021
  9. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
    Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
    PubMed     Abstract available

    November 2021
  10. I D, Okuno T, Heg D, Grani C, et al
    Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
    Am Heart J. 2021 Nov 14. pii: S0002-8703(21)00447.
    PubMed     Abstract available

    September 2021
  11. STRANGE JE, Sindet-Pedersen C, Gislason GH, Torp-Pedersen C, et al
    Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00239.
    PubMed     Abstract available

  12. CLARK KA, Chouairi F, Kay B, Reinhardt SW, et al
    Trends in Transcatheter and Surgical Aortic Valve Replacement in the United States, 2008-2018.
    Am Heart J. 2021 Sep 24. pii: S0002-8703(21)00232.
    PubMed     Abstract available

  13. DESAI MY, Wolski K, Owens A, Naidu SS, et al
    Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy.
    Am Heart J. 2021;239:80-89.
    PubMed     Abstract available

    June 2021
  14. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available

    April 2021
  15. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.

    March 2021
  16. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available

  17. LOWENSTERN A, Sheridan P, Wang TY, Boero I, et al
    Sex Disparities in Patients with Symptomatic Severe Aortic Stenosis.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00074.
    PubMed     Abstract available

  18. WAKSMAN R, Torguson R, Medranda GA, Shea C, et al
    Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.
    Am Heart J. 2021 Mar 10. pii: S0002-8703(21)00071.
    PubMed     Abstract available

    January 2021
  19. ADACHI Y, Yamamoto M, Shimura T, Yamaguchi R, et al
    Late kidney injury after transcatheter aortic valve replacement.
    Am Heart J. 2021 Jan 14. pii: S0002-8703(21)00011.
    PubMed     Abstract available

  20. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

    December 2020
  21. MENTIAS A, Sarrazin MV, Desai M, Kapadia S, et al
    Expansion of Transcatheter Aortic Valve Replacement in the United States: Expansion of TAVR in US.
    Am Heart J. 2020 Dec 31. pii: S0002-8703(20)30427.
    PubMed     Abstract available

    November 2020
  22. KAWASHIMA H, Soliman O, Wang R, Ono M, et al
    Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.
    Am Heart J. 2020 Nov 5. pii: S0002-8703(20)30368.
    PubMed     Abstract available

  23. LACHTRUPP CL, Valente AM, Gurvitz M, Landzberg MJ, et al
    Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease.
    Am Heart J. 2020;229:92-99.
    PubMed     Abstract available

    October 2020
  24. NATHAN AS, Yang L, Geng Z, Dayoub EJ, et al
    Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.
    Am Heart J. 2020;232:1-9.
    PubMed     Abstract available

  25. GUIMARAES HP, de Barros E Silva PGM, Liporace IL, Sampaio RO, et al
    A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
    Am Heart J. 2020 Oct 9. pii: S0002-8703(20)30277.
    PubMed     Abstract available

    August 2020
  26. AZEVEDO O, Marques N, Reis L, Cruz I, et al
    Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
    Am Heart J. 2020;226:114-126.
    PubMed     Abstract available

    July 2020
  27. BHARDWAJ B, Cohen DJ, Vemulapalli S, Kosinski AS, et al
    Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.
    Am Heart J. 2020;228:57-64.
    PubMed     Abstract available

  28. HERKERT JC, Verhagen JMA, Yotti R, Haghighi A, et al
    Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
    Am Heart J. 2020;225:108-119.
    PubMed     Abstract available

    June 2020
  29. ELTCHANINOFF H, Bonaros N, Prendergast B, Nietlispach F, et al
    Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve interventio
    Am Heart J. 2020;228:27-35.
    PubMed     Abstract available

  30. HOLMES DR JR, Mack MJ, Alkhouli M, Vemulapalli S, et al
    Racial disparities and democratization of health care: A focus on TAVR in the United States.
    Am Heart J. 2020;224:166-170.

    April 2020
  31. LUDWIG S, Gossling A, Waldschmidt L, Linder M, et al
    TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification.
    Am Heart J. 2020;225:138-148.
    PubMed     Abstract available

  32. DAMLUJI AA, Rodriguez G, Noel T, Davis L, et al
    Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
    Am Heart J. 2020;224:171-181.
    PubMed     Abstract available

    March 2020
    Consequences of impressive myectomy results in a Center of Excellence: The paradox of evidence-based medicine era.
    Am Heart J. 2020;221:157-158.

  34. GESKE JB, Driver CN, Yogeswaran V, Ommen SR, et al
    Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy.
    Am Heart J. 2020;221:159-164.
    PubMed     Abstract available

    February 2020
  35. PINEDA AM, Rymer J, Wang A, Banks AZ, et al
    Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.
    Am Heart J. 2020;224:105-112.
    PubMed     Abstract available

  36. ROZENBAUM Z, Finkelstein A, Zhitomirsky S, Topilsky Y, et al
    Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Am Heart J. 2020;220:184-191.
    PubMed     Abstract available

    January 2020
  37. KALBACHER D, Tigges E, Boekstegers P, Puls M, et al
    Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.
    Am Heart J. 2020;222:73-82.
    PubMed     Abstract available

  38. LU DY, Ventoulis I, Liu H, Kudchadkar SM, et al
    Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Am Heart J. 2020;219:58-69.
    PubMed     Abstract available

    December 2019
  39. MEGALY M, Gossl M, Sorajja P, Anzia LE, et al
    Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement.
    Am Heart J. 2019;218:128-132.
    PubMed     Abstract available

    October 2019
  40. VENN RA, Ning M, Vlahakes GJ, Wasfy JH, et al
    Surgical timing in infective endocarditis complicated by intracranial hemorrhage.
    Am Heart J. 2019;216:102-112.
    PubMed     Abstract available

    August 2019
  41. PAPOUTSIDAKIS N, Heitner S, Ingles J, Semsarian C, et al
    Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude.
    Am Heart J. 2019;214:28-35.
    PubMed     Abstract available

    March 2019
  42. PRIROMPRINTR B, Silka MJ, Rhodes J, Batra AS, et al
    A prospective 5-year study of exercise performance following Melody valve implant.
    Am Heart J. 2019;209:47-53.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.